Interatrial Shunt Devices Global Market Report 2025
상품코드:1810925
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
심방간 션트 장치 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 연평균 복합 성장률(CAGR) 10.2%로 성장할 전망이며, 42억 8,000만 달러로 성장이 예측됩니다. 예측 기간 동안 예상되는 성장은 심부전 유병률 증가, 노인 인구 확대, 침습성 심장 치료에 대한 인식 증가, 헬스케어 지출 증가, 카테터 기반 치료 채택 확대 등과 관련이 있습니다. 이 기간의 주요 동향에는 션트 장비 재료의 기술 혁신, 기술 중심의 인터벤션 기기의 소형화, 실시간 이미징 및 네비게이션 기술의 통합, 카테터 기반 전달 방법의 진보, 혈행 동태 모니터링 시스템의 개선 등이 포함됩니다.
심부전의 유병률 증가는 향후 수년간 심방간 션트 장치 시장의 성장을 이끌 것으로 예측됩니다. 심부전은 심장이 혈액을 효과적으로 송출할 수 없고, 몸의 조직에 산소나 영양소 공급이 불충분해지는 상태입니다. 심부전 환자 증가는 심장의 펌프 기능을 서서히 약화시키는 고혈압의 이환율 증가로 인한 것이 큽니다. 심방간 션트 장치는 좌심방과 우심방 사이에 작은 개구부를 만들고, 과부하의 좌심방으로부터 여분의 압력을 우심방으로 이동시킴으로써 완화시켜 심부전의 관리를 지원합니다. 이렇게 하면 폐 울혈이 완화되고 증상이 완화됩니다. 예를 들어, 미국을 거점으로 하는 전문 조직인 미국 심부전 학회는 2024년 9월, 20세 이상의 미국인 중 약 670만 명이 심부전을 안고 생활하고 있다고 보고했습니다. 이 수치는 2050년에는 1,140만 명으로 증가할 것으로 예측됩니다. 그 결과, 심부전의 유병률 증가가 심방간 션트 장치 시장의 확대를 뒷받침하고 있습니다.
심방간 션트 장치 시장의 주요 기업은 심부전 환자의 좌방압을 낮추는 것을 목표로 하는 새로운 션트 기술의 안전성과 효능을 평가하기 위한 퍼스트 인 휴먼(FIH) 임상시험과 같은 혁신적인 개발에 주력하고 있습니다. 인간 초임상 시험은 전임상 연구가 성공한 후 안전성, 내약성, 초기 효능을 평가하기 위해 새로운 의료기기 및 의약품을 인간에서 시험하는 초기 단계입니다. 예를 들어, 2025년 1월 미국의 의료기술 기업인 Adona Medical Inc.는 심부전 치료를 위해 설계된 신규 심방간 션트에 대한 인간 최초(FIH) 임상시험 ATHENS-HF의 등록을 완료했습니다. 이 장비는 치료 션트와 통합된 양심방압 모니터링을 결합한 최초의 하나이며, 보다 적응적이고 개별화된 심부전 관리 방법을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 심방간 션트 장치 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 심방간 션트 장치 시장 : 성장률 분석
세계의 심방간 션트 장치 시장 실적 : 규모 및 성장(2019-2024년)
세계의 심방간 션트 장치 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 심방간 션트 장치 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 심방간 션트 장치 시장 : 장비 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
이식형 션트 장비
일시적인 션트 장비
세계의 심방간 션트 장치 시장 : 전달 방법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
외과적 전달
경 카테터 전달
세계의 심방간 션트 장치 시장 : 재료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
니티놀
폴리에스테르
폴리프로필렌
세계의 심방간 션트 장치 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
선천성 심장병
심부전
뇌졸중 예방
세계의 심방간 션트 장치 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
외래수술센터(ASC)
심장 카테터 검사실
다른 사용자
세계의 심방간 션트 장치 시장 : 임베디드형 션트 장비 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
싱글 루멘 션트 장비
확장형 션트 장비
멀티 루멘 션트 장비
세계의 심방간 션트 장치 시장 : 일시적 션트 장비 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
풍선 보조 션트 장비
경피적 임시 션트 장비
카테터 기반 션트 장비
제7장 지역별 및 국가별 분석
세계의 심방간 션트 장치 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 심방간 션트 장치 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
심방간 션트 장치 시장 : 경쟁 구도
심방간 션트 장치 시장 : 기업 프로파일
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Medtronic plc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Terumo Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Edwards Lifesciences Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Cook Medical
Integra LifeSciences Holdings Corporation
Lepu Medical Technology(Beijing) Co. Ltd.
B. Braun Melsungen AG.
WL Gore & Associates Inc.
Venus Medtech Inc.
Occlutech Holding AG.
Wuhan Vickor Medical Technology Co. Ltd.
Corvia Medical Inc.
Xeltis BV
Alleviant Medical Inc.
Cerevasc Inc.
Adona Medical Inc.
Carag AG.
InterShunt Technologies Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
심방간 션트 장치 시장(2029년) : 새로운 기회를 제공하는 국가
심방간 션트 장치 시장(2029년) : 새로운 기회를 제공하는 부문
심방간 션트 장치 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Interatrial shunt devices are implantable medical tools developed to create a controlled passage between the left and right atria of the heart, aiming to lower pressure and alleviate symptoms in heart failure patients. These devices help redirect blood flow from the left atrium to the right atrium, effectively reducing elevated left atrial pressure associated with heart failure.
The primary types of interatrial shunt devices include implantable shunt devices and temporary shunt devices. Implantable shunt devices are designed to create a regulated connection between different body compartments and are typically used to redirect fluid or pressure for therapeutic purposes. These devices can be placed via surgical procedures or transcatheter methods. Common construction materials include nitinol, polyester, and polypropylene. They are primarily used in the treatment of congenital heart defects, heart failure, and stroke prevention, and are employed across various healthcare settings such as hospitals, ambulatory surgical centers, cardiac catheterization labs, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The interatrial shunt devices market research report is one of a series of new reports from The Business Research Company that provides interatrial shunt devices market statistics, including the interatrial shunt devices industry's global market size, regional shares, competitors with the interatrial shunt devices market share, detailed interatrial shunt devices market segments, market trends and opportunities, and any further data you may need to thrive in the interatrial shunt devices market. This interatrial shunt devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The interatrial shunt devices market size has grown rapidly in recent years. It will grow from $2.63 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth during the historic period can be attributed to increasing clinical evidence validating efficacy and safety, heightened demand for effective pulmonary hypertension management, a rising incidence of related comorbidities, more regulatory approvals for investigational shunt systems, and a growing preference for outpatient and ambulatory cardiac care.
The interatrial shunt devices market size is expected to see rapid growth in the next few years. It will grow to $4.28 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The expected growth in the forecast period can be linked to the increasing prevalence of heart failure, an expanding elderly population, heightened awareness of minimally invasive cardiac procedures, rising healthcare spending, and greater adoption of catheter-based treatments. Key trends during this period include innovations in shunt device materials, technology-driven miniaturization of interventional devices, integration of real-time imaging and navigation technologies, advancements in catheter-based delivery methods, and improvements in hemodynamic monitoring systems.
The increasing prevalence of heart failure is expected to drive the growth of the interatrial shunt devices market in the coming years. Heart failure is a condition where the heart cannot pump blood effectively, leading to insufficient delivery of oxygen and nutrients to the body's tissues. The rise in heart failure cases is largely due to the growing incidence of hypertension, which gradually weakens the heart's pumping ability. Interatrial shunt devices assist in managing heart failure by creating a small opening between the left and right atria, allowing excess pressure from the overloaded left atrium to be relieved by transferring it to the right atrium. This helps reduce pulmonary congestion and alleviates symptoms. For example, in September 2024, the Heart Failure Society of America, a US-based professional organization, reported that approximately 6.7 million Americans aged 20 and older were living with heart failure in 2024. This figure is expected to rise to 11.4 million by 2050. Consequently, the growing prevalence of heart failure is propelling the expansion of the interatrial shunt devices market.
Key players in the interatrial shunt devices market are concentrating on innovative developments, such as first-in-human (FIH) clinical trials to assess the safety and effectiveness of new shunt technologies aimed at lowering left atrial pressure in heart failure patients. A first-in-human clinical trial is the initial phase of testing a new medical device or drug in humans to evaluate safety, tolerability, and early efficacy following successful preclinical research. For instance, in January 2025, Adona Medical Inc., a US-based medical technology company, completed enrollment for its first-in-human (FIH) clinical trial, ATHENS-HF, involving a novel interatrial shunt designed for heart failure treatment. This device is among the first to combine therapeutic shunting with integrated bi-atrial pressure monitoring, offering a more adaptive and personalized method of managing heart failure.
In October 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired V-Wave Ltd. for an undisclosed sum. This acquisition aims to strengthen Johnson & Johnson's cardiovascular portfolio by adding advanced heart failure therapies and addressing critical unmet needs in the sector. V-Wave Ltd. is an Israel-based medical device firm specializing in innovative interatrial shunt devices.
Major players in the interatrial shunt devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc., Terumo Corporation, Edwards Lifesciences Corporation, Cook Medical, Integra LifeSciences Holdings Corporation, Lepu Medical Technology (Beijing) Co. Ltd., B. Braun Melsungen AG., W. L. Gore & Associates Inc., Venus Medtech Inc., Occlutech Holding AG., Wuhan Vickor Medical Technology Co. Ltd., Corvia Medical Inc., Xeltis BV, Alleviant Medical Inc., Cerevasc Inc., Adona Medical Inc., Carag AG., InterShunt Technologies Inc.
North America was the largest region in the interatrial shunt devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interatrial shunt devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the interatrial shunt devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The interatrial shunt devices market consists of sales of catheter-based delivery tools, transseptal access kits, monitoring accessories, and procedure-specific consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Interatrial Shunt Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on interatrial shunt devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for interatrial shunt devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interatrial shunt devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Interatrial Shunt Devices Market Trends And Strategies
4. Interatrial Shunt Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Interatrial Shunt Devices Growth Analysis And Strategic Analysis Framework
5.1. Global Interatrial Shunt Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Interatrial Shunt Devices Market Growth Rate Analysis
5.4. Global Interatrial Shunt Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Interatrial Shunt Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Interatrial Shunt Devices Total Addressable Market (TAM)
6. Interatrial Shunt Devices Market Segmentation
6.1. Global Interatrial Shunt Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Implantable Shunt Devices
Temporary Shunt Devices
6.2. Global Interatrial Shunt Devices Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgical Delivery
Transcatheter Delivery
6.3. Global Interatrial Shunt Devices Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nitinol
Polyester
Polyproplene
6.4. Global Interatrial Shunt Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Congenital Heart Disease
Heart Failure
Stroke Prevention
6.5. Global Interatrial Shunt Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
Other Users
6.6. Global Interatrial Shunt Devices Market, Sub-Segmentation Of Implantable Shunt Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Lumen Shunt Devices
Expandable Shunt Devices
Multi-Lumen Shunt Devices
6.7. Global Interatrial Shunt Devices Market, Sub-Segmentation Of Temporary Shunt Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Balloon-Assisted Shunt Devices
Percutaneous Temporary Shunt Devices
Catheter-Based Shunt Devices
7. Interatrial Shunt Devices Market Regional And Country Analysis
7.1. Global Interatrial Shunt Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Interatrial Shunt Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
